WO2001075060A3 - A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001075060A3
WO2001075060A3 PCT/CN2001/000527 CN0100527W WO0175060A3 WO 2001075060 A3 WO2001075060 A3 WO 2001075060A3 CN 0100527 W CN0100527 W CN 0100527W WO 0175060 A3 WO0175060 A3 WO 0175060A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
discloses
cystein protease
human
Prior art date
Application number
PCT/CN2001/000527
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001075060A2 (en
Inventor
Yumin Mao
Yi Xie
Original Assignee
Biowindow Gene Dev Inc
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biowindow Gene Dev Inc, Yumin Mao, Yi Xie filed Critical Biowindow Gene Dev Inc
Priority to AU60033/01A priority Critical patent/AU6003301A/en
Publication of WO2001075060A2 publication Critical patent/WO2001075060A2/en
Publication of WO2001075060A3 publication Critical patent/WO2001075060A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

The present invention discloses a novel polypeptide, a human cystein protease 9, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, development disorders, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the human cystein protease 9.
PCT/CN2001/000527 2000-03-29 2001-03-26 A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide WO2001075060A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU60033/01A AU6003301A (en) 2000-03-29 2001-03-26 A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00115292A CN1315574A (en) 2000-03-29 2000-03-29 Polypeptide-human cysteine protein 9 and polynucleotide for coding it

Publications (2)

Publication Number Publication Date
WO2001075060A2 WO2001075060A2 (en) 2001-10-11
WO2001075060A3 true WO2001075060A3 (en) 2002-03-14

Family

ID=4584760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000527 WO2001075060A2 (en) 2000-03-29 2001-03-26 A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1315574A (en)
AU (1) AU6003301A (en)
WO (1) WO2001075060A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026280A1 (en) * 1995-02-21 1996-08-29 Basf Aktiengesellschaft NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026280A1 (en) * 1995-02-21 1996-08-29 Basf Aktiengesellschaft NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME

Also Published As

Publication number Publication date
AU6003301A (en) 2001-10-15
CN1315574A (en) 2001-10-03
WO2001075060A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001075060A3 (en) A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001083688A3 (en) A novel polypeptide, a human subunit 13 phosphatidylinositol-4-phosphate-5-kinase ii beta and the polynucleotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001075048A3 (en) A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide
WO2001075053A3 (en) A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide
WO2002000821A3 (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001083685A3 (en) A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001075007A3 (en) A novel polypeptide, a tyrosinase 15 and the polynucleotide encoding the polypeptide
WO2002000823A3 (en) A novel polypeptide, a enzymatic activation protein ras gtp 9.57 and the polynucleotide encoding the polypeptide
WO2001077287A3 (en) A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide
WO2001083681A3 (en) A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide
WO2001064866A1 (en) A novel polypeptide, a ribosome s19e protein 11 and the polynucleotide encoding the polypeptide
WO2001075061A3 (en) A novel polypeptide, cdv-1-42 and the polynucleotide encoding the polypeptide
WO2001083682A3 (en) A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2002000828A3 (en) A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide
WO2001081538A3 (en) A novel polypeptide, a human connexin 9 and the polynucleotide encoding the polypeptide
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075057A3 (en) A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP